Nirvana Life Sciences
UnverifiedIs focused on developing medical.
Market cap
CAD482k
Net debt
(CAD20.5k)
Enterprise valuation
$369k (Public information from Jun 2024)
Share price
CAD0.01 NIRV.CN
Vancouver British Columbia (HQ)
| CAD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||